英文名稱 Anti-CD82/KAI1

中文名稱 腫瘤轉(zhuǎn)移抑制蛋白1抗體

濃 度 1mg/1ml

規(guī) 格 0.1ml/100μg 0.2ml/200μg

抗體來源 Rabbit

交叉反應(yīng) Human, Mouse, Rat, Dog, Pig, Cow, Horse

產(chǎn)品類型 一抗

研究領(lǐng)域 腫瘤 免疫學(xué) 信號轉(zhuǎn)導(dǎo) 轉(zhuǎn)錄調(diào)節(jié)因子 細(xì)胞表面分子 細(xì)胞類型標(biāo)志物 t-淋巴細(xì)胞

蛋白分子量 predicted molecular weight: 29kDa

性 狀 Lyophilized or Liquid

免 疫 原 KLH conjugated synthetic peptide derived from humanCD82 C-terminus

亞 型 IgG

純化方法 affinity purified by Protein A

儲 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Soiumzde

產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500

（石蠟切片需做抗原修復(fù)）

not yet tested in other applications.

optimal dilutions/concentrations should be determined by theend user.

保存條件  Store at -20 °C for one year.

別 名 4F9; Antigen detected by monoclonal and antibody IA4;C33; C33 antigen; CD 82; CD82 antigen; CD82 molecule; GR 15; GR15; IA 4; IA4;Inducible membrane protein; Inducible membrane protein R2; KAI 1; KAI1; Kangai1; Kangai1; Metastasis suppressor Kangai 1; Metastasis suppressor Kangai1; R2leukocyte antigen; CD82_HUMAN.